You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 21, 2024

TOPROL-XL Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Toprol-xl patents expire, and when can generic versions of Toprol-xl launch?

Toprol-xl is a drug marketed by Toprol and is included in one NDA.

The generic ingredient in TOPROL-XL is metoprolol succinate. There are sixty drug master file entries for this compound. Forty-nine suppliers are listed for this compound. Additional details are available on the metoprolol succinate profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Toprol-xl

A generic version of TOPROL-XL was approved as metoprolol succinate by ACTAVIS LABS FL INC on August 3rd, 2009.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for TOPROL-XL?
  • What are the global sales for TOPROL-XL?
  • What is Average Wholesale Price for TOPROL-XL?
Drug patent expirations by year for TOPROL-XL
Recent Clinical Trials for TOPROL-XL

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
AgoneX Biopharmaceuticals, Inc.Phase 2
BioHealthonomics Inc.Phase 2
MedtronicPhase 2

See all TOPROL-XL clinical trials

Pharmacology for TOPROL-XL

US Patents and Regulatory Information for TOPROL-XL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Toprol TOPROL-XL metoprolol succinate TABLET, EXTENDED RELEASE;ORAL 019962-004 Feb 5, 2001 AB RX Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Toprol TOPROL-XL metoprolol succinate TABLET, EXTENDED RELEASE;ORAL 019962-003 Jan 10, 1992 AB RX Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Toprol TOPROL-XL metoprolol succinate TABLET, EXTENDED RELEASE;ORAL 019962-001 Jan 10, 1992 AB RX Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Toprol TOPROL-XL metoprolol succinate TABLET, EXTENDED RELEASE;ORAL 019962-002 Jan 10, 1992 AB RX Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for TOPROL-XL

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Toprol TOPROL-XL metoprolol succinate TABLET, EXTENDED RELEASE;ORAL 019962-002 Jan 10, 1992 ⤷  Sign Up ⤷  Sign Up
Toprol TOPROL-XL metoprolol succinate TABLET, EXTENDED RELEASE;ORAL 019962-002 Jan 10, 1992 ⤷  Sign Up ⤷  Sign Up
Toprol TOPROL-XL metoprolol succinate TABLET, EXTENDED RELEASE;ORAL 019962-001 Jan 10, 1992 ⤷  Sign Up ⤷  Sign Up
Toprol TOPROL-XL metoprolol succinate TABLET, EXTENDED RELEASE;ORAL 019962-004 Feb 5, 2001 ⤷  Sign Up ⤷  Sign Up
Toprol TOPROL-XL metoprolol succinate TABLET, EXTENDED RELEASE;ORAL 019962-003 Jan 10, 1992 ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.